Schedule of Pharmaceutical Benefits - 1 June 2022

PBAC

1 June 2022 - The June 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect.

The June issue of the Schedule includes a few new/revised listings:

  • Bortezomib (Bortezomib Ever Pharma) - new formulation
  • Rituximab (Ruxience) - new biosimilar medicine
  • Venetoclax (Venclexta) - new presentation

Read Summary of Changes


Michael Wonder

Posted by:

Michael Wonder